“Global E-coli Testing Market to reach a market value of 3.1 Billion by 2031 growing at a CAGR of 6.3%”
The Global E-coli Testing Market size is expected to reach $3.1 billion by 2031, rising at a market growth of 6.3% CAGR during the forecast period.
North America has experienced notable outbreaks of food-borne illnesses linked to E-coli contamination in foods like ground beef, leafy greens, and other produce. This has heightened the demand for routine E-coli testing in the food industry to prevent outbreaks and protect public health. The region has a well-developed healthcare infrastructure with numerous hospitals, clinics, and diagnostic laboratories equipped with advanced diagnostic technologies. The high healthcare delivery and diagnostic testing capacity contributes to the significant demand for E-coli testing. Thus, the North America region segment acquired 39% revenue share in the market 2023.
Personalized medicine approaches involve close monitoring and management for individuals with chronic or recurrent E-coli infections. Advanced E-coli testing technologies enable regular and detailed assessment of infection status, allowing for personalized treatment and adjustments to management strategies.
Additionally, companies continuously develop and introduce new products as the food and beverage industry grows. Each new product requires rigorous testing to ensure it is free from E-coli and other contaminants. This demand for safety in new product lines contributes to the growth of the E-coli testing market. Therefore, the growing food and beverage industry is driving growth.
However, advanced testing technologies, such as molecular diagnostics (e.g., PCR), next-generation sequencing (NGS), and automated systems, often require substantial financial investment. This includes costs for purchasing equipment, maintaining and calibrating it, and training personnel to use it effectively.
On the basis of end user, the market is segmented into hospitals, diagnostic laboratories, and physicians’ offices. In 2023, the diagnostic laboratories segment attained 43% revenue share in the market. Hospitals experience a high volume of patients with diverse medical conditions, increasing the likelihood of encountering E-coli infections.
Based on the test, the market is divided into environmental test and clinical test. The clinical test segment witnessed 32% revenue share in the market in 2023. E-coli-related infections are increasing, including urinary tract infections (UTIs), bloodstream infections, and gastrointestinal illnesses.
Free Valuable Insights: Global E-coli Testing Market size to reach USD 3.1 Billion by 2031
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 25% revenue share in the market. The Asia Pacific region is experiencing rapid urbanization and industrialization, which can lead to increased pollution and contamination of water sources.
| Report Attribute | Details |
|---|---|
| Market size value in 2023 | USD 1.9 Billion |
| Market size forecast in 2031 | USD 3.1 Billion |
| Base Year | 2023 |
| Historical Period | 2020 to 2022 |
| Forecast Period | 2024 to 2031 |
| Revenue Growth Rate | CAGR of 6.3% from 2024 to 2031 |
| Number of Pages | 161 |
| Number of Tables | 249 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Test, End User, Region |
| Country scope |
|
| Companies Included | BIOMÉRIEUX, Bio-Rad Laboratories, Inc., Pro Lab diagnostics, NanoLogix, Inc., Thermo Fisher Scientific, CPI International, Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.), Becton, Dickinson and Company, and IDEXX Laboratories, Inc. |
By Test
By End User
By Geography
This Market size is expected to reach $3.1 billion by 2031.
Increased focus on personalized medicine are driving the Market in coming years, however, High costs of advanced testing technologies restraints the growth of the Market.
BIOMÉRIEUX, Bio-Rad Laboratories, Inc., Pro Lab diagnostics, NanoLogix, Inc., Thermo Fisher Scientific, CPI International, Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.), Becton, Dickinson and Company, and IDEXX Laboratories, Inc.
The expected CAGR of this Market is 6.3% from 2024 to 2031.
The Environmental Test segment is leading the Market by Test in 2023; thereby, achieving a market value of $2.1 billion by 2031.
The North America region dominated the Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1.2 billion by 2031.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 